Biogam Disease Interactions
There is 1 disease interaction with Biogam (immune globulin intramuscular).
Immune globulin IV/SQ/IM (applies to Biogam) thrombosis
Major Potential Hazard, Moderate plausibility. Applicable conditions: Hyponatremia, Diabetes Mellitus, Cardiovascular Disease, Polycythemia, History - Thrombotic/Thromboembolic Disorder
Thrombosis has been reported after treatment with immune globulin products. In general, patients at greatest risk of thromboembolic events are those of advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors; therefore, it is recommended that patients treated with these agents should be monitored for signs and symptoms of thrombosis and assess blood viscosity in patients at risk. Consider baseline assessment of blood viscosity in patients at risk for hyperviscosity.
Switch to professional interaction data
Biogam drug interactions
There are 22 drug interactions with Biogam (immune globulin intramuscular).
Report options
More about Biogam (immune globulin intramuscular)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.